Preparing Documentation to Support Clinical Supply Manufacture - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Preparing Documentation to Support Clinical Supply Manufacture
This article is written to assist clinical manufacturing representatives at pharmaceutical companies who are faced for the first time with outsourcing the manufacture of clinical supplies. The author describes the identification, writing, and execution of documents required to support the contract manufacture of products for clinical studies.


Pharmaceutical Technology


5. P.A. Josephs and M.A. Iacobucci, "Selecting a Contract Manufacturing Provider," Pharm. Technol., Contract Services (supplement), 72–80 (1999).

6. W. Lowry Caudill, "Making Outsourcing a Success: A View from Both Sides," Pharm.Technol., Contract Services (supplement), 20–26 (1999).

7. D. Feuerhelm and G.S. Blank, "Documentation: It's Not Just Paper Work," BioPharm International 14 (8), 18–21, 64 (2001).

8. V. Hedgecock, "Preparing for Preapproval Inspections at Contract Manufacturers," Amer. Pharm. Outsourcing 3 (6), 23–34 (Nov. 2002).

9. R.P. Blasini, "Quality Agreements between Pharmaceutical and Biopharmaceutical Companies and Their Contractors," BioPharm International 18 (4), 66–74 (2005).

10. D. Rosenkrantz, "Quality Considerations for Managing Contract Service Providers," Amer. Pharm. Outsourcing 3 (3), 20–24 (2002).

11. International Organization for Standardization, ISO 2859-1:1999: Sampling Procedures for Inspection by Attributes, Part I: Sampling Schemes Indexed by Acceptance Quality Limit (AQL) for Lot-by-Lot Inspection (ISO, Geneva, Switzerland, 1995).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here